Analytical Data
-
基因名
C1orf8
- Application
-
别名
TMEM59; C1orf8; HSPC001; UNQ169/PRO195; Transmembrane Protein 59; Liver membrane-bound Protein
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q9BXS4
-
表达区间
37-323aa
-
氨基酸序列
AFDSVLGDTASCHRACQLTYPLHTYPKEEELYACQRGCRLFSICQFVDDGIDLNRTKLECESACTEAYSQSDEQYACHLGCQNQLPFAELRQEQLMSLMPKMHLLFPLTLVRSFWSDMMDSAQSFITSSWTFYLQADDGKIVIFQSKPEIQYAPHLEQEPTNLRESSLSKMSYLQMRNSQAHRNFLEDGESDGFLRCLSLNSGWILTTTLVLSVMVLLWICCATVATAVEQYVPSEKLSIYGDLEFMNEQKLNRYPASSLVVVRSKTEDHEEAGPLPTKVNLAHSEI
-
分子量
35.5 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Recombinant Human RAI2 Protein，His
Cat：PAX2000-10738
Recombinant E.coli gadA Protein，His
Cat：PA2000-2336
Protein Description
C1orf8, also known as the chromosome 1 open reading frame 8, has emerged as a significant focus of research due to its potential implications in various biological processes and diseases. Initially identified through genomic studies, C1orf8 is believed to encode a protein that plays a role in cellular functions, including growth, differentiation, and apoptosis. Its expression patterns have been linked to several types of cancer, prompting investigations into its role as a potential biomarker and therapeutic target. Recent studies have utilized recombinant protein techniques to produce C1orf8 in order to elucidate its structure-function relationship and interactions with other cellular molecules. This approach enables researchers to dissect the molecular mechanisms underlying its activity and ascertain its implications in oncogenesis and other pathologies. Moreover, advances in proteomic technologies have facilitated the study of C1orf8's post-translational modifications and their effects on protein function and stability. Understanding C1orf8 at the biochemical level could reveal novel insights into its contributions to disease mechanisms and lead to the development of targeted therapies. Therefore, the research surrounding C1orf8 recombinant protein not only enhances our understanding of its biological roles but also holds promise for future clinical applications in precision medicine.
